{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:53:44Z","timestamp":1779144824437,"version":"3.51.4"},"reference-count":24,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4017,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1002\/humu.20081","type":"journal-article","created":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T22:00:53Z","timestamp":1090879253000},"page":"199-207","source":"Crossref","is-referenced-by-count":44,"title":["Identification and molecular characterization of \u03b1-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy"],"prefix":"10.1155","volume":"24","author":[{"given":"G.","family":"Yogalingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-H.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.J.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.D.","family":"Kakkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1002\/humu.20081-BIB1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/bj2840789","article-title":"Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase","volume":"284","author":"Anson","year":"1992","journal-title":"Biochem J"},{"key":"10.1002\/humu.20081-BIB2","first-page":"787","article-title":"Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients","volume":"50","author":"Ashton","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20081-BIB3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/humu.1380060119","article-title":"Mucopolysaccharidosis type I: identification of 13 novel mutations of the alpha-L-iduronidase gene","volume":"6","author":"Bunge","year":"1995","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20081-BIB4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","article-title":"Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies","volume":"1407","author":"Bunge","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/humu.20081-BIB5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/humu.1380030316","article-title":"Mutation analysis of 19 North American MPS type I patients: identification of two additional frequent mutations","volume":"3","author":"Clarke","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20081-BIB6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1985.tb09158.x","article-title":"Human alpha-L-iduronidase. 1. Purification, monoclonal antibody production, native and subunit molecular mass","volume":"152","author":"Clements","year":"1985","journal-title":"Eur J Biochem"},{"key":"10.1002\/humu.20081-BIB7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/cs0620193","article-title":"Diagnostic enzymology of \u03b1-L-iduronidase with special reference to a sulphated disaccharide derived from heparin","volume":"62","author":"Hopwood","year":"1982","journal-title":"Clin Sci"},{"key":"10.1002\/humu.20081-BIB8","first-page":"381","article-title":"The mucopolysaccharidoses: diagnosis, molecular genetics and treatment","volume":"7","author":"Hopwood","year":"1990","journal-title":"Mol Biol Med"},{"key":"10.1002\/humu.20081-BIB9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"10.1002\/humu.20081-BIB10","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/humu.20081-BIB11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.20081-BIB12","first-page":"425","article-title":"Mucopolysaccharidosis type I: identification and characterization of mutations affecting \u03b1-L-iduronidase activity","volume":"101","author":"Lee-Chen","year":"2002","journal-title":"J Formos Med Assoc"},{"key":"10.1002\/humu.20081-BIB13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.20081-BIB14","first-page":"999","article-title":"Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles","volume":"40","author":"Menon","year":"1994","journal-title":"Cell Mol Biol"},{"key":"10.1002\/humu.20081-BIB15","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1093\/nar\/18.17.5322","article-title":"pEF-BIOS, a powerful mammalian expression vector","volume":"18","author":"Mizushima","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/humu.20081-BIB16","first-page":"2465","volume-title":"The metabolic bases of inherited disease","author":"Neufeld","year":"1995"},{"key":"10.1002\/humu.20081-BIB17","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1002\/humu.20081-BIB18","first-page":"802","article-title":"Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3","volume":"47","author":"Scott","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20081-BIB19","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1073\/pnas.88.21.9695","article-title":"Human \u03b1-L-iduronidase: cDNA isolation and expression","volume":"88","author":"Scott","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.20081-BIB20","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/0888-7543(92)90053-U","article-title":"Structure and sequence of the human \u03b1-L-iduronidase gene","volume":"13","author":"Scott","year":"1992","journal-title":"Genomics"},{"key":"10.1002\/humu.20081-BIB21","first-page":"973","article-title":"Identification of mutations in the \u03b1-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes","volume":"53","author":"Scott","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20081-BIB22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/humu.1380060403","article-title":"Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical and biological implications","volume":"6","author":"Scott","year":"1995","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20081-BIB23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bj3040043","article-title":"Recombinant \u03b1-L-iduronidase: characterisation of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts","volume":"304","author":"Unger","year":"1994","journal-title":"Biochem J"},{"key":"10.1002\/humu.20081-BIB24","doi-asserted-by":"crossref","first-page":"27259","DOI":"10.1074\/jbc.271.44.27259","article-title":"Feline mucopolysaccharidosis type VI: characterisation of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease","volume":"271","author":"Yogalingam","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.20081","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/humu.20081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:51:35Z","timestamp":1672332695000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.20081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.20081","relation":{},"ISSN":["1059-7794","1098-1004"],"issn-type":[{"value":"1059-7794","type":"print"},{"value":"1098-1004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}